Gamification for Medication Adherence in High Blood Pressure and Cholesterol
Trial Summary
What is the purpose of this trial?
A two-arm randomized controlled trial to evaluate whether a gamification intervention plus involvement of a supportive partner (social support) and sending reports to physicians (accountability) increases medication adherence in patients with hypertension and hyperlipidemia. The study will randomize 84 patients with hypertension, hyperlipidemia, and a history of poor medication adherence seen in a single Penn Medicine clinic to an 18-week gamification intervention or to attention control text messages alone.
Do I need to stop my current medications for this trial?
The trial does not require you to stop your current medications. In fact, you need to have been prescribed blood pressure and statin medications for over a year to participate.
What data supports the effectiveness of gamification for medication adherence in high blood pressure and cholesterol?
Is gamification for medication adherence safe for humans?
How does the gamification treatment for medication adherence in high blood pressure and cholesterol differ from other treatments?
This treatment is unique because it uses gamification (applying game-like elements) to encourage patients to stick to their medication schedule by offering real-world rewards and video feedback, which is different from traditional methods that don't typically incorporate these engaging, interactive elements.13489
Research Team
Alexander Fanaroff, MD, MHS
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for patients with high blood pressure and cholesterol who have struggled to take their medications regularly. They must own a smartphone, have had a recent blood pressure reading over 140 mm Hg, been on specific meds for over a year, and not taken them as prescribed in the last 6 months. Those with very high blood pressure or less than 6 months to live cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a gamification intervention or attention control text messages to improve medication adherence
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- HTN and Medication Adherence
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor